Skip to content

Evaluation of the Use of Multimedia to Enhance Patient and Family Understanding

Evaluation of the Use of Multimedia to Enhance Patient and Family Understanding

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01152775
Enrollment
60
Registered
2010-06-29
Start date
2010-04-30
Completion date
2013-01-31
Last updated
2012-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Role of Multimedia on Retention and Comprehension of Key Concepts for Surgical Options in Newly Diagnosed Breast Cancer Patients.

Keywords

partnered surgical decision-making, impact of multimedia-based teaching, patient education, understanding and retention by patients

Brief summary

This study will investigate the potential impact of arts-informed, technology-based patient education material, and specifically, the role of multimedia imagery on patient comprehension, perceived satisfaction, anxiety levels, and informed decision-making.

Detailed description

Based on an inter-professional approach to support a new role in patient care, this research addresses both literacy and health literacy issues within the context of current challenges to healthcare delivery and associated fragmentation in continuity of care. Patient education is a key component in the delivery of comprehensive care and it is the potential for on-line patient education that provides the basis for research.

Interventions

OTHERThis group of patients will be exposed to multimedia

This group of patients will be exposed to multimedia

OTHERNo Media

This group will not be exposed to multimedia

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

The following inclusion criteria will be used: Participants must be: 1. Newly diagnosed breast cancer patients 2. A minimum age of 18 years or older 3. Able to read and write in English and/or French 4. Have a confirmed diagnosis of any of the following: 1. Infiltrating ductal carcinoma 2. Ductal carcinoma in situ (Grade III) 3. Lobular carcinoma in situ (Grade III) 4. Infiltrating lobular carcinoma 5. Have access to, and the ability to use, a computer

Exclusion criteria

* The following criteria will be reasons for exclusion from the study: 1. The participant has a serious psychiatric or cognitive impairment that would prevent the patient from completing the study requirements. 2. The participant has a previous history of breast cancer

Design outcomes

Primary

MeasureTime frameDescription
Concept Grid1 yearA likert scale measuring the comprehension and retention of key concepts in the research study.

Secondary

MeasureTime frameDescription
DCS Conflict Scale1 yearTraditional Decision Conflict Scale - The decisional conflict scale measures personal perceptions of: a) uncertainty in choosing options; b) modifiable factors contributing to uncertainty such as feeling uninformed, unclear about personal values and unsupported in decision making; and c) effective decision making such as feeling the choice is informed, values-based, likely to be implemented and expressing satisfaction.
Anxiety Scale - A.S. Zigmond and R.P. Snaith1 yearA self-assessment scale that has been developed and found to be a reliable instrument for detecting states of depression and anxiety in the setting of a hospital medical outpatient clinic. This questionnaire is designed to help the doctor know how you feel.
The Hospital Anxiety and Depression (HAD) Scale1 yearThe Hospital Anxiety and Depression (HAD) rating scale is a commonly used questionnaire. It is a screening questionnaire for psychiatric disorders.
Interactive Patient Education Oncology Module1 yearWe would like to know if the module helped the patient understand their disease and their available treatment options. It is a questionnaire to obtain feedback on its overall design.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026